A balanced diet rich in fibre, lean protein, and healthy fats supports satiety and helps maintain a caloric deficit over time
N Engl J Med 390(6):497509
Obesity is highly associated with an array of non-communicable diseases including cardiovascular disease (CVD), type 2 diabetes, dyslipidemia, kidney disease, site-specific cancers, and musculoskeletal disorders [2, 3]

Rybelsus (semaglutide) is a GLP-1 receptor agonist that does not cause physical dependence or withdrawal symptoms when stopped abruptly Discontinuing Rybelsus leads to rising blood glucose levels, increased appetite, and potential weight regain as the medication's effects diminish over 45 weeks Stopping without medical supervision and an alternative diabetes management plan increases risk of poor glycaemic control and long-term complications NICE and MHRA guidance recommend discussing any medication changes with your healthcare team to ensure continuity of diabetes management Safe discontinuation requires monitoring blood glucose levels, implementing lifestyle strategies, and potentially starting alternative medications under medical supervision Table of Contents What Happens When You Stop Taking Rybelsus Suddenly Rybelsus (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist used to improve glycaemic control in adults with type 2 diabetes mellitus

And if not, they may be able to recommend an alternative